Benesch Advises Preferred Vascular Group in Strategic Sale to Surgery Partners

Benesch is pleased to announce that it served as legal counsel to Preferred Vascular Group (PVG) in its recent acquisition by Surgery Partners (NASDAQ: SGRY), a leading operator of surgical facilities and ancillary services. This transaction marks a significant step in expanding access to high-quality vascular care and advancing outpatient solutions for dialysis patients.

Founded in 2005, PVG is a leading Ambulatory Surgical Center (ASC) operator in Georgia and Ohio. This transaction represents a pivotal development for both organizations, positioning PVG to accelerate its growth and scale its innovative care nationally, while enabling Surgery Partners to enter the $6 billion dialysis access market and strengthen its presence in the broader vascular market.

“We’re proud to have advised PVG on this significant milestone,” said Jason Greis, one of the lead partners on the transaction. “This partnership enables PVG to further its mission and reach more patients, and we look forward to watching their continued growth as they pursue this next chapter.”

The Benesch team was led by Healthcare Partners Jason Greis and Christopher DeGrande and included Pamela Polevoy, Kathrin Zaki, Shil Mehta and Brenda Horton.

Read more.